GHRP-6 CJC-1295 DAC Blend Peptide Vial

Description

GHRP-6 CJC-1295 DAC Blend Peptide Vial

GHRP-6 CJC-1295 DAC Blend offers the convenience of being able to utilise two popular peptides without the need of buying and administering each one individually. Peptides supplied in sterile glass vials can maintain stability and integrity by preventing contamination which is required for clinical research purposes. Furthermore, glass vials can preserve the efficacy of the research compounds by protecting peptides from external factors like light and air.

In addition, peptide vials give a degree of flexibility for research methods by allowing dosages to be changed depending on intended outcomes of the study.

Specifications

GHRP-6 1.7mg

GHRP-6 is a six amino acid hexapeptide which is also a Growth Hormone Releasing Peptide. GHRP-6 works to promote growth hormone (GH) by stimulating GH production while inhibiting Somatostatin. The pituitary gland, once activated, facilitates the brain’s process.

GHRP6 is linked to anti-aging, weight loss and muscle growth. Although this peptide has no yet been approved for human consumption, studies using animals suggest that GHRP-6 has a significant effect on muscle growth and fat loss.

Find out more about GHRP-6 Peptide here.

CJC-1295 DAC 0.8mg

The hypothalamus, a tiny area near the base of the brain, produces growth hormone-releasing hormone. Its release from the hypothalamus encourages the pituitary gland to release Growth Hormone. However, due to its extremely short half-life of only a few minutes, this hormone can be ineffective.

The active section of the growth hormone comprises the first 29 amino acids and is referred to as Sermorelin. This peptide was changed to increase its half-life to 30 minutes, thus by increasing its effectiveness; it is now known as CJC 1295. Furthermore, the peptide was altered by adding DAC (Drug Affinity Complex), extending its half-life to eight days.

Recent scientific research shows that CJC 1295 with DAC boosts metabolism, increases weight loss, and helps maintain healthy body weight.

Discover the potential clinical applications, benefits and side effects of CJC-1295 DAC peptide here.

GHRP-6 CJC-1295 DAC Blend Research Benefits

When combined, GHRP-6 CJC-1295 DAC Blend peptides work together to create a continuous and potent release of growth hormone, optimizing the body’s ability to build and repair muscle tissues. This combination not only supports muscle hypertrophy but also aids in reducing body fat, enhancing metabolism, and promoting better sleep, which is crucial for recovery and overall health.

Additionally, the increase in growth hormone levels caused by GHRP-6 CJC-1295 DAC blend can contribute to anti-aging effects, such as improved skin elasticity and vitality. Together, GHRP-6 and CJC-1295 DAC form a dynamic duo that offers comprehensive benefits for those seeking enhanced physical performance, recovery, and longevity.

Buy GHRP-6 CJC-1295 DAC Blend Online

Pharma Lab Global is one of the best locations to purchase high purity GHRP-6 CJC-1295 DAC for laboratory research use. Pharma Lab Global website is a trusted supplier of peptides worldwide. Buy research peptides online from Pharma Lab Global.

References

[1] Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7.

[2] Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805.

[3] Fernández-Mayola M, Betancourt L, Molina-Kautzman A, Palomares S, et al. Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study. Int Wound J. 2018 Aug;15(4):538-546.

[4] Subirós N, Pérez-Saad HM, Berlanga JA, Aldana L, García-Illera G, Gibson CL, García-Del-Barco D. Assessment of dose-effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy. Neurol Res. 2016 Mar;38(3):187-95.

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY

DISCLAIMER: All products sold by Pharma Lab Global are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.